Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making.
Tadrous M, Aves T, Fahim C, Riad J, Mittmann N, Prieto-Alhambra D, Rivera DR, Chan K, Lix LM, Kent S, Dawoud D, Guertin JR, McDonald JT, Round J, Klarenbach S, Stanojevic S, De Vera MA, Strumpf E, Platt RW, Husein F, Lambert L, Hayes KN.
Tadrous M, et al. Among authors: kent s.
J Clin Epidemiol. 2024 Sep 23;176:111545. doi: 10.1016/j.jclinepi.2024.111545. Online ahead of print.
J Clin Epidemiol. 2024.
PMID: 39322123
Free article.